MS patients who achieve long-term stable disease on disease-modifying therapy may want to stop their medication for varying ...

Different people can have different types of MS, and disease progression and symptoms range greatly from person to person. For both reasons, each person’s treatment plan will be different.

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.

Switching therapies is a common part of multiple sclerosis management and may be considered for several reasons.

The FDA has advised health care professionals and patients with multiple sclerosis that treatment with glatiramer acetate is ...

Both MS and fibromyalgia may cause chronic pain and fatigue, they are very distinct conditions. A correct diagnosis is important to ensure proper treatment. Multiple sclerosis (MS) is an ...

A new study revealed safe MS treatment options during pregnancy, reassuring women to balance effective care with their plans ...

Columnist Ben Hofmeister reflects on his journey treating depression and what he wishes he knew earlier about MS and mental health.

Overall, women with MS have a 26% increased risk of mental illness during pregnancy and a 33% increased risk after giving birth, compared to women without the degenerative nerve disease.

Two key symptoms that can arise soon after a diagnosis of multiple sclerosis (MS) could predict how swiftly the illness will progress and suggest best treatment options, new research shows.

The National Multiple Sclerosis Society (NMSS) has launched the first national guidelines for the treatment of Multiple ...